Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Preventing Coronary Artery Aneurysm in Kawasaki Disease
NCT01917721Phase 2Active, not recruiting
- Sponsor
- Hawaii Pacific Health
- Start
- Oct 2013
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Kawasaki disease (KD) and coronary artery aneurysm (CAA) comparing Doxycycline with Placebo (2 arms). Primary endpoint: Coronary Artery Diameter Z-score Change at 8 weeks. Started Oct 2013; status: active, not recruiting.
02
Drugs
doxycycline
03
Conditions
Kawasaki disease (KD)coronary artery aneurysm (CAA)
Beyond the preview
Go deeper on NCT01917721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917721.